High field MRI in clinical practice
24 October 2012
Download Type: Adobe PDF
One of the most important unmet needs in the development of new drugs as well as the delivery and monitoring of new medicinal entities is the development of new biomarkers that can be used as (surrogate) endpoints to assess the therapeutic effect. Imaging, combining high-resolution spatial information with specific functional and molecular information, is making important inroads in producing such new biomarkers.
Peter R. Luijten and Dennis W.J. Klomp discuss the ultra high field MRI and complementary imaging technology and applications beyond the brain.